Vor Biopharma Inc. Common Stock (VOR)
Vor Biopharma Inc. (VOR) is a biotechnology company focused on developing targeted therapies for cancer using cell engineering technologies. The company aims to create treatments that selectively eliminate cancer cells while preserving healthy cells, leveraging its proprietary gene-editing platforms. Founded to address challenges in oncology, Vor Biopharma emphasizes precision medicine approaches to improve patient outcomes.
Company News
Vor Bio granted stock options and restricted stock units to seven newly hired employees under their 2023 Inducement Plan, with options vesting over a four-year period.
Vor Biopharma (VOR) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
A more selective small-cap index has consistently outperformed the Russell 2000